胰岛素非注射给药途径研究的新进展论(4)

　　3 Lowman AM, Morishita M, Kajita M, et al. Oral delivery of insulin using pH-responsive complexation gels. J Pharm Sci , 1999, 88(9)：933~937
　　4 Mathiowitz E, Jacob JS, Jong YS, et al. Biologically erodable microspheres as potential oral drug delivery systems. Nature, 1997, 386：410~414
　　5 Damge C, Michel C, Apranhamian M, et al， New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes, 1988, 37：246~251
　　6 Duan MX, Yue ZC, Ma H, et al. State of insulin encapsulated by polyalkylcyanoacrylate nanoparticles. Proceed Intern Symp Poly. Drug Del, (Boston,1999) 351
　　7 Aboubakar M, Puisieux F, Couvreur P et al. Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. J Biomed Mater Res, 1999，47(4)：568~576
　　8 张 强, 丁继军，叶国庆 等，口服胰岛素毫微球的体外释药及对糖尿病大鼠的降血糖作用。药学学报，1998，33(2)：152~156
　　9 Muramatsu K, Maitani Y， Nagai T. Dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols and cholesterol as a carrier for the oral administration of insulin in rats. Biol Pharm Bull, 1996,199(8)：1055~1058
　　10 Iwanaga K, Ono S, Narioka K, et al. Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin. J Pharm Sci, 1999 88(2)：248~252
　　11 New RRC, Kirby CJ. Solubilisation of hydrophilic drugs in oily fromulations. Adv Dru Del Rev，1997,24：59~69
　　12 Kawashima Y, Yamamoto H, Takeuchi, et al, Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.. J Controlled Release, 1999 ,62(1-2)：279~287
　　13 沈赞聪，张强，魏树礼. 胰岛素毫微球肺部给药对正常大鼠的降血糖作用. 北京医科大学学报1999,31(5)：436~438 （科教论文网 lw.nSeAc.com编辑发布）
　　14 Edwards DA, Hanes J, Caponetti G, et al, Large Porous particles for pulmonary drug delivery. Science, 1997, 276：1868~1871
　　15 Laube BL, Georgopoulos A, Adams III GK. Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients. JAMA, 1993,269(16)：2106~2109
　　16 Laube BL, Benedict GW, Dobs AS. Time to peak insulin level, relative bioavailability, and effect of site of deposition of nebulized insulin in patients with noninsulin-dependent diabetes mellitus. J Aerosol Med ,1998,11(3)：153~173
　　17 Laube BL, Benedict WG, Dobs AS. The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes. Chest, 1998,114：1734~1739
　　18 Chakraborti RN. Bronchopulmonary absorption of aerosolised insulin. J Indian Med Assoc, 1999,97(12)：493~495.
　　19 Kupila A, Sipila J, Simell T, et al. Effects of intranasal insulin in healthy subjects. Presented at the American Diabetes Association 58th Scientific Sessions,Chicago, Illinois, June 1998
　　20 Rivera VM, Wang X, Wardwell S, et al. Regulation of Protein Secretion Through Controlled Aggregation in the Endoplasmic Reticulum.. Science, 2000, 287：816~817, 826~830